Thymosin beta-4 (Tβ4) is a full-length, 43-amino-acid protein your body makes in nearly every cell. TB-500 is a synthetic peptide, most often described as a short fragment built around Tβ4's actin-binding region, though some sellers use the name for synthetic full-length Tβ4. They are related but not interchangeable, and most published research was done on full-length Tβ4, not on the TB-500 fragment.
The Short Answer: Related, Not Identical
Thymosin beta-4 is the natural protein. TB-500 is a lab-made peptide modeled on part of it. People use the two names as if they mean the same thing. That habit causes most of the confusion online.
This matters for three practical reasons:
- What you're buying. A product labeled TB-500 could contain a 7-amino-acid fragment or a synthetic copy of the full 43-amino-acid protein. Those are different molecules.
- What the research covers. Most studies people quote were done on full-length Tβ4. Applying them to a short fragment is an assumption, not a finding.
- How to judge claims. If a seller can't tell you which molecule is in the bottle, they can't honestly tell you which studies apply to it.
The rest of this guide covers each piece: what Tβ4 is, what TB-500 usually means, which research belongs to which, and how to check a label.
What Thymosin Beta-4 Actually Is
Thymosin beta-4 is a small, naturally occurring protein that helps cells manage actin, the protein behind cell shape and movement. It is 43 amino acids long, weighs roughly 4.9 kDa, and is found in most human cells and tissues. It is also highly conserved across species, which means its sequence has changed very little over evolution.
Its best-understood job is binding G-actin, the single-unit form of actin. By holding onto actin units, Tβ4 helps control when and where cells build actin filaments. Cells need that for moving, changing shape, and organizing their internal structure. That is why researchers have studied Tβ4 for cell migration and tissue repair processes.
Two regions of the protein get the most attention:
- Residues 17–23 (sequence LKKTETQ): the core actin-binding motif.
- Residues 1–4 (Ac-SDKP): an N-terminal fragment that can be cleaved off and has been studied as its own molecule.
For a deeper look at what the full protein has been studied for, see our guide to thymosin beta-4 benefits.
What 'TB-500' Means, and Why the Label Varies
TB-500 is a trade-style name, not a standardized scientific term, so its meaning depends on who's selling it. The name came out of performance and veterinary circles, not from a single defined pharmaceutical compound. That's why you'll see it used in two different ways.
Meaning 1: the fragment. In many sources, TB-500 refers to a synthetic, acetylated version of the 17–23 region (Ac-LKKTETQ). That's a 7-amino-acid peptide weighing under 1 kDa, about one-sixth the size of the full protein. The idea behind it is to isolate the actin-binding motif in a smaller, simpler-to-make molecule.
Meaning 2: synthetic full-length Tβ4. Some suppliers use 'TB-500' as a catch-all label for lab-made thymosin beta-4 with the full 43-amino-acid sequence.
Both uses are common, and neither is wrong as marketing. But they describe different molecules. The fragment holds one functional region of the protein. The full-length version holds every region, including the N-terminal segment that the fragment leaves out. When you read 'TB-500' on a label, the right question is: which one? Our TB-500 benefits article covers what's been explored for the peptide specifically.
Side-by-Side: TB-500 vs. Thymosin Beta-4
The core difference is size and completeness: Tβ4 is the whole protein, while TB-500 (in its most common definition) is one piece of it. Here's how they compare:
- Origin: Tβ4 is made by your body. TB-500 is synthesized in a lab.
- Length: Tβ4 has 43 amino acids. TB-500 has 7 (fragment form) or 43 (if the seller means synthetic full-length).
- Molecular weight: Tβ4 is about 4.9 kDa. The TB-500 fragment is under 1 kDa.
- Regions included: Tβ4 includes the full sequence, including Ac-SDKP and the actin-binding motif. The TB-500 fragment includes only the actin-binding motif (17–23).
- Research depth: Tβ4 has decades of lab and animal research plus some early-stage human research on specific formulations. TB-500 as a fragment has much thinner published research.
- Naming: Tβ4 is a precise scientific name. TB-500 is an informal name used inconsistently.
The short version: every claim about Tβ4 is a claim about the whole protein. A fragment may share some activity, but that has to be shown for the fragment itself.
Research Attribution: Which Studies Apply to Which Molecule
Most published research is on full-length thymosin beta-4. Treat it as evidence about the protein, not automatically about TB-500. This is the biggest honesty gap in how these peptides get marketed.
Here is roughly how the research breaks down:
- Full-length Tβ4: Studied in cell cultures and animal models for its role in cell migration, new blood vessel formation, and tissue repair processes. Some early-stage human research has looked at specific topical and eye formulations. These are formulation-specific findings, not general proof of benefit.
- The actin-binding fragment (17–23): Some lab research suggests this region carries part of Tβ4's actin-related and cell-migration activity. That helps explain why a fragment was developed at all. Still, the body of direct fragment research is much smaller than the full-protein literature.
- Ac-SDKP (1–4): Studied separately, in its own research line. Its findings belong to that tetrapeptide, not to the 17–23 fragment, which doesn't contain it.
What research does not show: There is no large body of controlled human research establishing outcomes for the TB-500 fragment. Most peptide research also used injected or topical delivery, so findings don't automatically carry over to other formats. A responsible reading is: Tβ4 is a well-studied protein; TB-500 is studied for overlapping mechanisms; human evidence for either as a supplement is limited.
If an article cites 'thymosin beta-4 studies' to sell a TB-500 product without saying which molecule the product contains, the citation is doing more work than it has earned.
What's Actually in a Product Labeled TB-500
You can only know what's in a TB-500 product by checking its label and its Certificate of Analysis (COA), not its name. Here is what to look for:
1. The sequence or molecule named on the label. Does it say 'TB-500 fragment,' 'Ac-LKKTETQ,' 'thymosin beta-4 fragment,' or 'thymosin beta-4 (full-length)'? Vague wording is a yellow flag. 2. A lot-specific COA. The COA should match the lot number on your bottle, not a generic sample from years ago. 3. Identity testing. Mass spectrometry confirms the molecule by weight. A result near 4.9 kDa points to full-length Tβ4. A result under 1 kDa points to the fragment. 4. Purity testing. HPLC shows how much of the material is the target peptide and how much is something else. 5. Contaminant screening. Look for testing on heavy metals and microbes, not just peptide content. 6. Where it's made. A named, registered manufacturing facility is easier to hold accountable than an anonymous source.
At Ageless Humans, every product is made in our FDA-registered facility in Carlsbad, California, and every lot is third-party lab tested with a COA. That's the standard you should expect from any peptide brand. If a company can't produce lot-matched testing, you have no way to know which molecule you're getting, or whether you're getting either one.
Regulatory and Sport Status: What to Know
Neither TB-500 nor thymosin beta-4 is an FDA-approved drug, and both are prohibited in tested sports. The World Anti-Doping Agency's Prohibited List names thymosin beta-4 and its derivatives, explicitly including TB-500. Athletes in tested competition should treat both as off-limits, whatever the format.
On the supplement side, peptide products sit in a changing regulatory space. Rules on which peptides can be sold, and in what forms, can shift. That's another reason to buy only from brands that make their products in registered facilities and publish lot-level testing.
A few practical guardrails:
- Follow label directions exactly. Don't stack or adjust amounts based on forum advice.
- Talk with your healthcare provider before starting any peptide product, especially if you take medications, are pregnant or nursing, or have a medical condition.
- Be skeptical of any seller promising to fix a specific medical problem. Supplements can support normal body functions. They are not medical treatments.
How to Read TB-500 and Tβ4 Claims Like an Expert
Ask three questions of any claim: which molecule, which study type, and which delivery format. Those three filters sort honest content from hype in seconds.
- Which molecule? If the claim says 'TB-500' but cites thymosin beta-4 research, the source is borrowing evidence from a related molecule.
- Which study type? Cell and animal research is valuable for understanding mechanisms. It is not the same as showing results in people.
- Which format? Results from injected or topical formulations don't automatically apply to oral products, and the reverse is also true.
Honest language sounds like 'studied for,' 'research suggests,' and 'supports.' Overconfident language sounds like guaranteed timelines, before-and-after promises, and disease names. Hold every brand, including ours, to the first standard.
Frequently asked questions
Is TB-500 the same as thymosin beta-4?+
No. Thymosin beta-4 is a natural 43-amino-acid protein found in most human cells. TB-500 is a synthetic peptide, most commonly a 7-amino-acid fragment based on Tβ4's actin-binding region (residues 17–23), though some sellers use the name for synthetic full-length Tβ4. Always check the label and Certificate of Analysis to see which molecule a product contains.
What is the TB-500 amino acid sequence?+
In its most common definition, TB-500 is the acetylated fragment Ac-LKKTETQ, which matches residues 17–23 of thymosin beta-4. This is the region of the protein most associated with binding actin. Because the name isn't standardized, confirm the sequence on a product's lot-specific COA.
Does thymosin beta-4 research apply to TB-500?+
Not automatically. Most published research was done on full-length thymosin beta-4, mainly in cell and animal models, with limited early-stage human research on specific formulations. The TB-500 fragment shares the actin-binding region, so some overlap in mechanism is plausible, but direct research on the fragment is much thinner.
How can I tell if a product contains full-length Tβ4 or the TB-500 fragment?+
Check the lot-specific Certificate of Analysis for mass spectrometry results. Full-length thymosin beta-4 weighs roughly 4.9 kDa, while the common TB-500 fragment is under 1 kDa. HPLC purity data and a clearly named sequence on the label are also signs of a transparent product.
Is TB-500 banned in sports?+
Yes. The World Anti-Doping Agency's Prohibited List includes thymosin beta-4 and its derivatives, and it names TB-500 specifically. Athletes subject to drug testing should avoid both, in any format.
Is TB-500 FDA-approved?+
No. Neither TB-500 nor thymosin beta-4 is an FDA-approved drug. If you use a peptide supplement, choose one made in a registered facility with third-party, lot-specific testing, follow label directions, and talk with your healthcare provider first.
